1,121
Views
6
CrossRef citations to date
0
Altmetric
Cardiovascular

The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty

ORCID Icon, , , , , & show all
Pages 356-364 | Received 13 Oct 2017, Accepted 05 Dec 2017, Published online: 15 Dec 2017

References

  • Chawla LS, Amdur RL, Shaw AD, Faselis C, Palant CE, Kimmel PL. Association between AKI and Long-Term Renal and Cardiovascular Outcomes in United States Veterans. Clinical Journal of the American Society of Nephrology: CJASN 2014;9:448-456
  • Bernier-Jean A, Beaubien-Souligny W, Goupil R, et al. Diagnosis and outcomes of acute kidney injury using surrogate and imputation methods for missing preadmission creatinine values. BMC Nephrol 2017;18:141
  • Heung M, Steffick DE, Zivin K, et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data. Am J Kidney Dis 2016;67:742-52
  • Ishani A, Nelson D, Clothier B, et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med 2011;171:226-33
  • Parr SK, Siew ED. Delayed consequences of acute kidney injury. Adv Chronic Kidney Dis 2016;23:186-94
  • Wu V-C, Wu C-H, Huang T-M, et al. Long-term risk of coronary events after AKI. J Am Soc Nephrol 2014;25:595-605
  • Mohammed NM, Mahfouz A, Achkar K, et al. Contrast-induced nephropathy. Heart Views Offic J Gulf Heart Assoc 2013;14:106
  • Goldfarb S, McCullough PA, McDermott J, Gay SB. Contrast-Induced Acute Kidney Injury: Specialty-Specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional Cardiology. Mayo Clinic Proceedings. 2009;84:170-179
  • Bucher AM, De Cecco CN, Schoepf UJ, et al. Is Contrast Medium Osmolality a Causal Factor for Contrast-Induced Nephropathy? BioMed Research International 2014;2014:1-6. doi:10.1155/2014/931413
  • McCullough PA, Brown JR. Effects of intra-arterial and intravenous iso-osmolar contrast medium (iodixanol) on the risk of contrast-induced acute kidney injury: a meta-analysis. Cardiorenal Med 2011;1:220-34
  • Aspelin P, Aubry P, Fransson S-G, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-9
  • Aspelin P, Aubry P, Fransson S-G, et al. Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy. Am Heart J 2005;149:298-303
  • Eng J, Wilson RF, Subramaniam RM, et al. Comparative effect of contrast media type on the incidence of contrast-induced nephropathy. A systematic review and meta-analysis comparative effect of contrast media type. Ann Intern Med 2016;164:417-24
  • Heinrich MC, Ha¨berle L, Mu¨ller V, et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009;250:68-86
  • Jo S-H, Youn T-J, Koo B-K, et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography. J Am Coll Cardiol 2006;48:924-30
  • Reed M, Meier P, Tamhane UU, et al. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. JACC: Cardiovasc Intervent 2009;2:645-54
  • Shin D-H, Choi D-J, Youn T-J, et al. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography. Am J Cardiol 2011;108:189-94
  • Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. Oxford, UK: Oxford University Press; 2015
  • Glick HA, Doshi JA, Sonnad SS, et al. Economic evaluation in clinical trials. Oxford: OUP; 2014
  • McCullough PA, David G, Todoran TM, et al. Iso-osmolar contrast media and adverse renal and cardiac events after percutaneous cardiovascular intervention. J Comparat Effectiv Res 2017 In Press (available electronically, not yet in print-doi: 10.2217/cer-2017-0052. [Epub ahead of print])
  • De Francesco M, Ronco C, Wacinski PJ, et al. Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain. J Med Econ 2016;19:168-78
  • CPI of US medical care services. Bureau of Labor Statistics (US Government). US Census. 2017; https://www.bls.gov
  • Premier Healthcare Database: data the informs and performs. Charlotte, NC: Premier Healthcare Database: Date that Informs and Preforms: 2017
  • Ernst FR, Chen E, Lipkin C, et al. Comparison of hospital length of stay, costs, and readmissions of alteplase versus catheter replacement among patients with occluded central venous catheters. J Hosp Med 2014;9:490-6
  • AHA. Fast Facts on US Hospitals 2017. Chicago, IL: AHA; 2017
  • National Center for Health Statistics.Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities. p.288. Hyattsville, MD. 2016
  • Census U. Census regions and divisions of the United States 2015; 2015 US Department of Labor (Bureau of Labor Services) Washington DC https://www.bls.gov/lau/laurdqa.htm#Q1
  • Gapenski LC. Healthcare finance. Ann Arbor, MI: Health Administration Press; 2007
  • Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Col Cardiol 2004;44:1393-9
  • Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365-70
  • Huber M, Ozrazgat-Baslanti T, Thottakkara P, et al. Mortality and cost of acute and chronic kidney disease after vascular surgery. Ann Vasc Surg 2016;30:72-81. e72
  • King SB, Smith SC, Hirshfeld JW, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. J Am Coll Cardiol 2008;51:172-209
  • National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis 2005;45:S1-S154
  • Amin AP, Bach RG, Caruso ML, et al. Association of variation in contrast volume with acute kidney injury in patients undergoing percutaneous coronary intervention. JAMA Cardiol 2017;2:1007-12
  • AHRQ. 2010-2013 Healthcare cost and utilization project (HCUP). Overview of the national inpatient sample. Rockville, MD: AHRQ
  • Stuntz M, Palac A. Recent trends in inpatient percutaneous coronary intervention volume in the United States: analysis of HCUP-NIS, 2010–2013. Paper presented at the International Society of Pharmcoeconomic and Outcomes Research (ISPOR); 2016 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research 29 October-02 November 2016 Vienna, Austria
  • Bortnick AE, Epps KC, Selzer F, et al. Five-year follow-up of patients treated for coronary artery disease in the face of an increasing burden of co-morbidity and disease complexity (from the NHLBI Dynamic Registry). Am J Cardiol 2014;113:573-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.